Save your place

Sign in to WhoBought

Please try again later.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) institutional ownership

Latest close $9.09 Jul 28, 2026
Market cap$114M 52-week range SectorHealthcare
Funds holding · Q2 2023
1
reported CRBP position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q2 2023
Activity unavailable N/A
0 buyers · 1 sellers

Corbus Pharmaceuticals Holdings, Inc. (CRBP) price and institutional activity

Dates

Q2 2023

$0 bought by 0 investors
$0 sold by 1 investors
Ifp Advisors, Inc
Bought Sold Totals per quarter; hover a bar for the names.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) institutional activity · 1

Investor Type Est. change Change Δ Own Date
Ifp Advisors, Inc · Exited
Change −100 Δ Own −100.0% Date Q2 2023
Ifp Advisors, Inc Exited· Q2 2023 −100 −100.0% Q2 2023
Data through Q2 2023 · filed Aug 10, 2023
1 of 1

Famous investor activity in Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Corbus Pharmaceuticals Holdings, Inc. (CRBP) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Kung Winston · Director Sell −$16K
Price $7.91 Qty −2K Owned 12K Trade date Jun 10, 2026 Filed date Jun 11, 2026
Kung Winston Director Sell $7.91 −2K −$16K 12K Jun 10, 2026 Jun 11, 2026
Altmeyer Anne · Director Sell −$19K
Price $7.91 Qty −2K Owned 8K Trade date Jun 10, 2026 Filed date Jun 11, 2026
Altmeyer Anne Director Sell $7.91 −2K −$19K 8K Jun 10, 2026 Jun 11, 2026
Jenkins John Kenneth · Director Sell −$38K
Price $7.91 Qty −5K Owned 4K Trade date Jun 10, 2026 Filed date Jun 11, 2026
Jenkins John Kenneth Director Sell $7.91 −5K −$38K 4K Jun 10, 2026 Jun 11, 2026
Saxena Nishant C. · Officer Buy +$68K
Price $7.58 Qty +9K Owned 75K Trade date Jun 3, 2026 Filed date Jun 3, 2026
Saxena Nishant C. Officer Buy $7.58 +9K +$68K 75K Jun 3, 2026 Jun 3, 2026
Saxena Nishant C. · Officer Buy +$33K
Price $7.33 Qty +4K Owned 66K Trade date Jun 2, 2026 Filed date Jun 3, 2026
Saxena Nishant C. Officer Buy $7.33 +4K +$33K 66K Jun 2, 2026 Jun 3, 2026
Saxena Nishant C. · Officer 2 operations 251K
Owned 192K Trade date May 21, 2026 Filed date May 22, 2026
Saxena Nishant C. Officer 2 operations 251K 192K May 21, 2026 May 22, 2026
Kung Winston · Director 2 operations 16K
Owned 12K Trade date May 19, 2026 Filed date May 21, 2026
Kung Winston Director 2 operations 16K 12K May 19, 2026 May 21, 2026
Jacques Rachelle Suzanne · Director 2 operations 16K
Owned 12K Trade date May 19, 2026 Filed date May 21, 2026
Jacques Rachelle Suzanne Director 2 operations 16K 12K May 19, 2026 May 21, 2026
Jenkins John Kenneth · Director 2 operations 16K
Owned 12K Trade date May 19, 2026 Filed date May 21, 2026
Jenkins John Kenneth Director 2 operations 16K 12K May 19, 2026 May 21, 2026
Altmeyer Anne · Director 2 operations 16K
Owned 12K Trade date May 19, 2026 Filed date May 21, 2026
Altmeyer Anne Director 2 operations 16K 12K May 19, 2026 May 21, 2026
Ben Yong · Director 2 operations 16K
Owned 12K Trade date May 19, 2026 Filed date May 21, 2026
Ben Yong Director 2 operations 16K 12K May 19, 2026 May 21, 2026
Pfeiffenberger Brent · Director 2 operations 32K
Owned 25K Trade date May 19, 2026 Filed date May 21, 2026
Pfeiffenberger Brent Director 2 operations 32K 25K May 19, 2026 May 21, 2026
Smethurst Dominic · Officer Sell −$51K
Price $8.30 Qty −6K Owned 90K Trade date Mar 2, 2026 Filed date Mar 4, 2026
Smethurst Dominic Officer Sell $8.30 −6K −$51K 90K Mar 2, 2026 Mar 4, 2026
Hodgson Ian · Officer Sell −$6K
Price $7.38 Qty −847 Owned 51K Trade date Feb 17, 2026 Filed date Feb 18, 2026
Hodgson Ian Officer Sell $7.38 −847 −$6K 51K Feb 17, 2026 Feb 18, 2026
Moran Sean F. · CFO Sell −$37K
Price $7.78 Qty −5K Owned 97K Trade date Feb 13, 2026 Filed date Feb 18, 2026
Moran Sean F. CFO Sell $7.78 −5K −$37K 97K Feb 13, 2026 Feb 18, 2026
15 of 31
15 of 31 Sign in to continue to older insider transactions.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Cormorant Asset Management, LP
% of shares outstanding 19.5% Filing date Nov 14, 2024
Cormorant Asset Management, LP 19.5% Nov 14, 2024
Cormorant Global Healthcare Master Fund, LP 1.5M
% of shares outstanding 14.3% Filing date Feb 5, 2024
Cormorant Global Healthcare Master Fund, LP 1.5M 14.3% Feb 5, 2024
ETF Managers Group, LLC 14.2M
% of shares outstanding 11.4% Filing date Jun 1, 2021
ETF Managers Group, LLC 14.2M 11.4% Jun 1, 2021
Tang Capital Partners LP 426K
% of shares outstanding 9.6% Filing date Jan 26, 2024
Tang Capital Partners LP 426K 9.6% Jan 26, 2024
Octagon Capital Advisors LP 1.1M
% of shares outstanding 9.3% Filing date Oct 11, 2024
Octagon Capital Advisors LP 1.1M 9.3% Oct 11, 2024
Point72 Asset Management, L.P. 389K
% of shares outstanding 8.8% Filing date Jan 29, 2024
Point72 Asset Management, L.P. 389K 8.8% Jan 29, 2024
K2 Healthventures Equity Trust LLC 10.5M
% of shares outstanding 7.8% Filing date Feb 14, 2024
K2 Healthventures Equity Trust LLC 10.5M 7.8% Feb 14, 2024
Adage Capital Partners Gp, L.L.C. 796K
% of shares outstanding 7.7% Filing date Feb 12, 2024
Adage Capital Partners Gp, L.L.C. 796K 7.7% Feb 12, 2024
8 of 23

Corbus Pharmaceuticals Holdings, Inc. (CRBP) ownership FAQ

Who owns CRBP?

1 reporting institutions disclosed CRBP position changes in the Q2 2023 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q2 2023.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.